Stanford University
Showing 8,501-8,600 of 12,886 Results
-
Jon Park, MD, FRCSC
Saunders Family Professor
Current Research and Scholarly InterestsNon-fusion dynamic spinal stabilization, artificial disc technologies, and regenerative spinal technologies.
-
Jun Hyung Park
Research and Development Science and Engineer 1, Rad/Molecular Imaging Program at Stanford
Current Role at StanfordI joined in Cyclotron and radiochemstry facility in 2014. I focus on routine radiopharmaceutical production, including 18F tracers (18F-Flumazenil, 18F-FTC-146, 18F-FLT, 18F Arag, 18F-FSPG etc.); 11C tracers (11C UCB-J, 11C-raclopride, 11C-PIB, 11C-methionine, 11C DPA-713 etc.); 15O-H2O and 68Ga-DOTATATE radiochemistry for clinical use and supporting various of pre-clinical studies.
-
Junyoung Park
Postdoctoral Scholar, Neurology and Neurological Sciences
BioDr. Jun Young graduated from the Department of Biostatistics at the School of Public Health, Seoul National University, Korea. His major field of study is biostatistics, with a specific focus on the application of machine learning and statistical analysis to medical imaging and genetic data. During his doctoral studies, he concentrated on two primary research areas. Firstly, he dedicated himself to the development of deep learning models for medical images, primarily centered on T1-MRI and cognitive function test images related to Alzheimer's Disease. Secondly, he engaged in extensive genome-wide association analyses of medical images associated with Alzheimer's Disease, using statistical algorithms to uncover novel insights into the genetic factors contributing to this complex condition. Currently, as a postdoctoral fellow at the Greicius Lab at Stanford, he aims to develop statistical methods to discover novel structural variants and model polygenetic risk scores using long-read sequencing data.
-
KT Park MD MS
Adjunct Professor, Medicine - Med/Gastroenterology and Hepatology
BioPrior to joining Genentech in 2018, Dr. Park was Associate Professor at Stanford University School of Medicine, Co-Director of the IBD Center at Stanford Children’s Health, and an expert in Crohn’s disease and ulcerative colitis. Currently, he is the Global Head of Gastroenterology, Hepatology & Metabolism in Product Development at Genentech and Roche. Trained as a health economist, during his tenure in academia, Dr Park held research grants and funding support focused on the cost-effectiveness of biologic treatment strategies and novel non-invasive biomarkers for children and adults with IBD. He led national research registries at the Crohn’s & Colitis Foundation and scientific/clinical committees in numerous GI societies and physicians’ organizations. He received his BA in chemistry/biochemistry at Duke University, MD at University of Tennessee, and MSc in Health Economics/Policy at Stanford where he completed his clinical and postdoctoral trainings. He is Adjunct Professor of Medicine in the Division of Gastroenterology & Hepatology at Stanford University. At Genentech Roche, Dr. Park directs a team of clinical scientists and medical directors overseeing clinical phase drug development in gastroenterology, hepatology, and metabolism.
-
Lesley Park
Senior Research Scientist, Epidemiology and Population Health
BioStanford Advancing Health Equity and Diversity (AHEaD)
ahead.stanford.edu
Founding Co-Director (2020-present)
Veterans Aging Cohort Study (VACS)
Executive Director (2022-present)
Cancer Core Co-Director (2016-present)
International Workshop on HIV and Hepatitis Observational Databases (IWHOD)
iwhod.org
Chair, Scientific Secretariat (2024-present)
Dr. Lesley Park is a co-founding director of the Stanford AHEaD summer research program for college students from underrepresented and historically excluded groups in the health sciences. She is also the Executive Director of the VACS consortium, an international collaboration of methodologists, clinicians, and trainees who utilize the rich and valuable data from the Veterans Health Administration to do impactful research. VACS has been at the forefront of research to understand aging with HIV to improve patient care, particularly with respect to alcohol and other substance use, physiologic frailty, and polypharmacy. In recent years, the VACS mission has expanded to encompass other foci, including genomic research and most recently COVID-19.
Within the VACS, Dr. Park oversees cancer and COVID-19 outcomes research in persons with HIV/AIDS (PWH). Her research experience has focused on the intersection of cancer and HIV, examining epidemiologic methods for cancer research, cancer incidence trends, and cancer (particularly hepatocellular carcinoma) prevention in PWH. Dr. Park is an experienced epidemiologist, skilled in "big data" observational research, survival analysis, and SAS programming. She teaches courses in computing, data management, and epidemiologic analysis methods. Her prior experience includes research at the Yale School of Medicine and at the Center for Biostatistics in AIDS Research (CBAR) at the Harvard School of Public Health.
The International Workshop on HIV and Hepatitis Observational Databases (IWHOD) is an established scientific forum for the appropriate application of real-world data to emerging issues in infectious disease. Dr. Park leads the IWHOD scientific committee of internationally reknowned experts in infectious disease and is responsible for administrative and scientific coordination of IWHOD.
Previously, Dr. Park was one of the leaders of the Stanford Center for Population Health Sciences (PHS). PHS aims to improve the health of populations by bringing together diverse disciplines and data to understand and address social, environmental, behavioral, and biological factors. She oversaw all of the educational and training initiatives at PHS and was one of the founding directors of the PHS Data Center and PHS Postdoctoral Fellowship program. -
Namu Park
Postdoctoral Scholar, Biomedical Informatics
BioDr. Park is a Postdoctoral Scholar at the Division of Computational Medicine at Stanford University, where he is co-advised by Dr. Tina Hernandez-Boussard and Dr. Yair Bannet. He received his PhD in Biomedical and Health Informatics from the University of Washington.
His research focuses on clinical natural language processing and large language models for healthcare. He develops clinically grounded information extraction methods and evaluation frameworks that reflect real-world clinical workflows. His work examines how large language models can be aligned with clinical reasoning and rigorously evaluated for safe and effective deployment in health systems.
Through interdisciplinary collaboration, Dr. Park aims to bridge advances in foundation models with measurable clinical impact, emphasizing reliability, transparency, and scalability in AI-driven healthcare applications. -
Walter Park
Professor of Medicine (Gastroenterology and Hepatology)
Current Research and Scholarly InterestsDr. Park's research interests are in the diagnosis and management of pancreatic cysts, acute and chronic pancreatitis. His approach incorporates methods in health services research including the use of observational datasets, cost-effectiveness studies, and the development of clinical cohorts.
-
Karen J. Parker, PhD
Truong-Tan Broadcom Endowed Professor and Professor, by courtesy, of Comparative Medicine
Current Research and Scholarly InterestsThe Parker Lab conducts research on the biology of social functioning in monkeys, typically developing humans, and patients with social difficulties.
-
Robertson Parkman
Other Teaching Staff-Hourly, Pediatrics - Stem Cell Transplantation
BioMy principal research interests have been the assessment of the immunological consequences of hematopoietic stem cell transplantation including both acute and chronic graft versus host disease and immune reconstitution and the use of hematopoietic stem cell transplantation to treat genetic diseases. My laboratory was the first to suggest that chronic graft versus host disease was an autoimmune disease directed at histocompatibility antigens shared by donors and recipients. The observation leaded to the assessment of the role of thymic dysfunction in the pathogenesis of chronic graft versus host disease. As a pediatric immunologist I have investigated the role of hematopoietic stem cell transplantation initially in the treatment of primary immune deficiency diseases and later the treatment of metabolic diseases, which lead to my involvement in the early gene transfer clinical trials.
-
Ugur Parlatan
Basic Life Research Scientist, Rad/Canary Center at Stanford for Cancer Early Detection
BioDr. Ugur Parlatan is a Basic Life Research Scientist at the Canary Center at Stanford for Cancer Early Detection. Trained as a physicist, he leads photonics laboratory activities and develops optical spectroscopy and imaging approaches for molecular fingerprinting and characterization of extracellular vesicles (EVs). His work includes designing and optimizing measurement workflows, analyzing EV signatures from biomedical samples, and supporting disease-focused studies across cancer and metabolic conditions (including lung cancer, glioblastoma, pancreatic cancer, diabetes, and hepatotoxicity). He also mentors trainees (including NIH CREST program interns) and contributes to manuscripts and grant applications.
-
Jane Parnes
Professor of Medicine, Emerita
Current Research and Scholarly InterestsThe lab is studying the mechanisms controlling B cell responsiveness and the balance between tolerance and autoimmunity. B cells deficient in CD72 are hyperresponsive to stimulation through the B cell receptor. We are examining the alterations in B cell signaling in these B cells and the mechanisms by which CD72 deficiency partially abrogates anergic tolerance. We hope to learn how deficiency in CD72 leads to spontaneous autoimmunity and increased susceptibility to induced autoimmune disease.
-
Shyon Parsa
Affiliate, Department Funds
Resident in MedicineBioShyon earned his B.S. in Biomedical Engineering from the Cockrell School of Engineering at the University of Texas - Austin, graduating with Honors. He completed coursework in Thermodynamics and Transport Phenomena in Living Systems at the Department of Applied Mathematics and Theoretical Physics at Cambridge University under Clare Hall fellow Dr. Kenneth Diller. After graduation, Shyon enrolled in medical school at UT Southwestern, and graduated with an M.D with Distinction in Research and as a member of the Alpha Omega Alpha (AOA) honor society.
He started his internal medicine residency at Stanford University Hospital in 2023. In 2024, he was awarded a Stanford Cardiovascular Institute Seed Grant for his project "An Artificial Intelligence Approach Utilizing Radiomic-Derived Calcium Features on Calcium Scoring CT (CAC-CT) in Cardiovascular Risk Stratification" (Co-PI). In 2025, he was selected for a Young Investigator Award from the National Lipid Association and named as an American Heart Association Early Career Investigator Award for Preventive Cardiovascular Medicine Research finalist. He is currently leading the NOTIFY-ASCVD trial alongside Co-PIs Fatima Rodriguez and Fahim Abbasi.
His interests include the use of AI in opportunistic coronary artery disease assessment, clinical integration of AI-based diagnostic algorithms through clinical trials, and preventive health advocacy through public policy. He plans to pursue a career in cardiology with a focus on advanced computational imaging techniques, medical device development, and advocacy both in his local communities and abroad. -
Susan Julia Parson
Clinical Assistant Professor (Affiliated), Pathology Clinical
Staff, Pathology Operations supported expensesBioAssistant Medical Examiner-Coroner / Forensic Pathologist
Santa Clara County Office of the Medical Examiner-Coroner
850 Thornton Way San Jose, CA 95128
(408) 793-1900
https://mec.santaclaracounty.gov/home -
Julie Parsonnet
George DeForest Barnett Professor of Medicine, Emerita
Current Research and Scholarly InterestsI am an infectious diseases epidemiologist who has done large field studies in both the US and developing countries. We research the long-term consequences of chronic interactions between the human host and the microbial world. My lab has done fundamental work establishing the role of H. pylori in causing disease and understanding its epidemiology. Currently, our research dissects how and when children first encounter microbes and the long term effects of these exposures on health.
-
Sonia Partap
Clinical Professor, Pediatric Neurology
Clinical Professor (By courtesy), NeurosurgeryCurrent Research and Scholarly InterestsMy research interests involve the epidemiology, treatment and diagnosis of pediatric and young adult brain tumors. I am also interested in long-term neurologic effects and designing clinical trials to treat brain and spinal cord tumors.
-
Gopanandan Parthasarathy
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioDr Nandan Parthasarathy is a hepatologist and physician-scientist in the Department of Gastroenterology and Hepatology at Stanford University.
After obtaining his medical degree in JIPMER, India, he completed a 2 year clinical research fellowship at Mayo Clinic, following which he completed his residency training at Cleveland Clinic, and GI and transplant hepatology fellowships at Mayo Clinic. During his fellowship, his research work was focused on exploring the immune mechanisms of liver injury in metabolic dysfunction associated steatohepatitis.
Clinically, he is focused on taking care of patients with MASH, cirrhosis and liver cancer.
His career goal is to study the gut-immune system-liver injury axis in order to bring novel therapeutics from the bench to bedside in patients with liver disease. -
Preethy Parthiban
Postdoctoral Scholar, Neonatal and Developmental Medicine
BioMy research centers on how the innate immune system shapes tissue remodeling in health and disease. During my PhD, I uncovered a key role for resident macrophages in driving cardiac fibrosis, identifying a macrophage-derived chemokine that directly activates cardiac fibroblasts. Building on this foundation, my postdoctoral work at Stanford focuses on neutrophil–macrophage crosstalk in disrupted alveolarization in neonatal mice and patients. By integrating cellular, molecular, and translational approaches, I aim to define how innate immune pathways orchestrate extracellular matrix remodeling. Ultimately, my goal is to identify critical therapeutic targets that improve outcomes in ECM-related diseases.
-
Akshay Paruchuri
Postdoctoral Scholar, Psychiatry
BioI'm currently a postdoctoral scholar in the Stanford Translational AI (STAI) lab led by Professor Ehsan Adeli. I earned my PhD in computer science at UNC Chapel Hill under the advisement of Professor Henry Fuchs. My research interests are at the intersection of health AI, computer vision, and machine learning. Currently, I'm working toward a future where next-generation healthcare systems improve the entire patient journey, from advanced diagnostic imaging and surgical support to all-day health monitoring and management, to achieve better therapeutic outcomes for cancer and aging-related diseases. I'm generally interested in opportunities that would allow me to continue to deepen my research expertise while leading and working on projects with meaningful, positive real-world impact, especially with respect to areas such as healthcare and environmental sustainability.
Previously, I was a visiting researcher at IDSIA USI-SUPSI working with Professor Piotr Didyk on the interpretability of multimodal language models (MLMs) with respect to capabilities such as visual perception. I've published in leading venues on topics such as remote health sensing (WACV, NeurIPS), 3D reconstruction (ECCV, MICCAI), LLM-based conversational agents for personal health (EMNLP, Nature Communications), and energy-efficient operation of smart glasses (ISMAR). I've done internships at Google AR/VR, Google Consumer Health Research, and Kitware. -
Josef Parvizi, MD, PhD
Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery
BioDr. Parvizi completed his medical internship at Mayo Clinic, neurology training at Harvard, and subspecialty training in clinical neurophysiology and epilepsy at UCLA before joining the Department of Neurology and Neurological Sciences at Stanford in 2007. Dr. Parvizi directs the Stanford Program for Medication Resistant Epilepsies and specializes in surgical treatments of intractable focal epilepsies. Dr. Parvizi is the principal investigator in the Laboratory of Behavioral and Cognitive Neuroscience, where he leads a team of investigators to study the human brain. http://med.stanford.edu/parvizi-lab.html.
Epilepsy patient story: https://www.youtube.com/watch?v=HXy-gXg0t94&t=3s -
Melissa Ann Pasao
Affiliate, Emergency Medicine
BioMelissa Pasao came to Stanford Emergency Medicine in November 2020 from UCLA with a Bachelors of Science in Neuroscience, and now with over three years of experience coordinating multi-site emergency medicine research studies, managing complex datasets and diverse teams, and ensuring regulatory compliance, Melissa’s role as a Health Services Research Program Coordinator has evolved to continuously leverage her project management expertise in support of impactful research initiatives. Recently obtaining her Project Management Professional Certification and with her continued passion for public health and equitable healthcare, Melissa continues to apply her skills and experience to contribute to the cutting-edge research being done with our health services research faculty and collaborators.
-
Anca M. Pasca, MD
Assistant Professor of Pediatrics
On Partial Leave from 01/05/2026 To 04/19/2026Current Research and Scholarly InterestsThe research focus of the lab is to understand molecular mechanisms underlying neurodevelopmental disorders associated with premature birth, neonatal and fetal brain injury with the long-term goal of translating the lab’s findings into therapeutics. The research team employs a multidisciplinary approach involving genetics, molecular and developmental neurobiology, animal models and neural cells differentiated from patient-derived induced pluripotent stem (iPS) cells. In particular, the lab is using a powerful 3D human brain-region specific organoid system developed at Stanford (Nature Methods, 2015; Nature Protocols, 2018) to ask questions about brain injury during development.
https://www.neopascalab.org/ -
Sergiu P. Pasca
Kenneth T. Norris, Jr. Professor of Psychiatry and Behavioral Sciences and Bonnie Uytengsu and Family Director of the Stanford Brain Organogenesis Program
Current Research and Scholarly InterestsA critical challenge in understanding the intricate programs underlying development, assembly and dysfunction of the human brain is the lack of direct access to intact, functioning human brain tissue for detailed investigation by imaging, recording, and stimulation.
To address this, we are developing bottom-up approaches to generate and assemble, from multi-cellular components, human neural circuits in vitro and in vivo.
We introduced the use of instructive signals for deriving from human pluripotent stem cells self-organizing 3D cellular structures named brain region-specific spheroids/organoids. We demonstrated that these cultures, such as the ones resembling the cerebral cortex, can be reliably derived across many lines and experiments, contain synaptically connected neurons and non-reactive astrocytes, and can be used to gain mechanistic insights into genetic and environmental brain disorders. Moreover, when maintained as long-term cultures, they recapitulate an intrinsic program of maturation that progresses towards postnatal stages.
We also pioneered a modular system to integrate 3D brain region-specific organoids and study human neuronal migration and neural circuit formation in functional preparations that we named assembloids. We have actively applied these models in combination with studies in long-term ex vivo brain preparations to acquire a deeper understanding of human physiology, evolution and disease mechanisms.
We have carved a unique research program that combines rigorous in vivo and in vitro neuroscience, stem cell and molecular biology approaches to construct and deconstruct previously inaccessible stages of human brain development and function in health and disease.
We believe science is a community effort, and accordingly, we have been advancing the field by broadly and openly sharing our technologies with numerous laboratories around the world and organizing the primary research conference and the training courses in the area of cellular models of the human brain. -
Magdalini Paschali
Postdoctoral Scholar, Radiology
Current Research and Scholarly InterestsMy research focuses on utilizing machine learning models to enhance the understanding, diagnosis, and treatment of clinical disorders. I am interested in multi-modal learning, combining imaging data like MRI and CT scans with non-imaging data such as electronic health records, creating more holistic and accurate diagnostic models. I am also interested in the robustness of deep neural networks under domain shifts, investigating how models perform when faced with changes in input data distributions.
Finally, I am interested in early biomarker identification using AI model interpretability, to enable the early detection and targeted treatment of chronic disorders. -
Alok Patel
Clinical Associate Professor, Pediatrics
BioAlok Patel is a pediatric hospitalist, medical journalist, on-camera expert, producer, and devotee of creative, engaging science communication tactics. He currently serves as the Faculty Director of Communications for the Department of Pediatrics. Through this role, he helps coordinate creative media strategies for awareness, education, advocacy, recruitment and more.
Dr. Patel has extensive experience in broadcast journalism, on-camera work, script writing, podcast hosting, media consulting, and designing social media campaigns and hopes to lend these skills to his work in public health messaging. He currently works as a pediatric hospitalist within the department of pediatrics at Lucile Packard Children's Hospital. -
Anisha I Patel
Professor of Pediatrics (General Pediatrics) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsDr. Patel is a physician-scientist with a focus on community-engaged research (CEnR). She works to translate evidence to impact policies that can benefit children facing inequities due to their racial/ethnic background, poverty, and/or geography.
She leads the independently-funded research program, Partnerships for Research in Child Health, which collaborates with community partners to co-develop, implement, and evaluate innovative interventions aimed at preventing obesity and cardiometabolic diseases in low-income, minoritized populations. Over the past 10 years, Dr. Patel has led numerous studies to encourage healthy beverage intake among children and adolescents. These studies include analyses of large national data sets, conduct of randomized controlled trials in schools, child care, and community settings to examine how interventions to increase children’s intake of water instead of sugar-sweetened beverages impact child health, and the evaluation of policy efforts to improve the healthfulness of beverages offered in schools and community settings.
Long before the Flint water crisis, Dr. Patel was working with partners to address nitrate and arsenic contamination in drinking water supplies in California’s San Joaquin Valley, a rural region home to many low-income Latinx farm-working families. She secured funding from the National Institute of Child Health and Human Development to collaborate with researchers, nonprofits, water utilities, families, and advocates to develop innovative solutions to drinking water contamination in the region, helping to lead to the Agua4All program. The Agua4All initiative increased access to safe drinking water by installing filtered water stations in schools and community sites. The program’s success led to its national expansion and informed a $16.3 million-dollar water in schools grant program as well as California legislation to improve safe water access in public schools. Dr. Patel’s work with collaborators and communities was recognized by First Lady Michelle Obama’s Drink Up campaign and featured in Stanford Medicine’s award-winning magazine.
As an expert in CEnR, Dr. Patel leads initiatives at Stanford. She is Director of the Office of Community-Engaged Research at Stanford's Maternal and Child Health Research Institute. In this role, she is helping to lead several initiatives, including expanding grant funding for CEnR and implementing capacity-building training programs for both community partners and the Stanford community. She also serves as Associate Dean of Research in Stanford’s School of Medicine, where she works to enhance community engagement across the university. Dr. Patel is a Co-Investigator on Stanford’s Clinical Translational Sciences Award. She also helps lead mentoring of fellows and junior faculty in CEnR.
Dr. Patel has a diverse funding portfolio ranging from the Robert Wood Johnson Foundation Healthy Eating Research Program, the W.K. Kellogg Foundation, and the National Institutes of Health. Dr. Patel has presented her research to local, national and international audiences. She has also been recognized for her research with awards from the American Academy of Pediatrics and the University of North Carolina, Chapel Hill School of Public Health. -
Chirag Patel, MD, PhD
Member, Cardiovascular Institute
Current Research and Scholarly InterestsNeuro-oncology, Clinical Trials, Tumor Treating Fields (TTFields), Molecular/PET Imaging, Neuroimaging, Immunotherapy, Big Data Analysis
-
Lisa Patel
Clinical Associate Professor, Pediatrics
BioLisa Patel received her undergraduate degree in Biological Sciences from Stanford University. After college, she worked in Egypt, Brazil, and India on international development projects with community-based organizations and non-profits, focusing on conservation and development efforts. She then obtained her Master's in Environmental Sciences from the Yale School of the Environment and went on to be a Presidential Management Fellow for the Environmental Protection Agency, coordinating the US Government's efforts on clean air and safe drinking water projects in South Asia in collaboration with the World Health Organization for which she was awarded the Trudy A. Specinar Award.
Realizing the critical and inextricable links between children's health and environmental issues, she obtained her medical degree from Johns Hopkins University and completed her residency in pediatrics at UCSF. For the last several years, she has used her extensive experience working for government, community organizations, and non-profits to advocate for children's health priorities in the US. She is previously the co-chair for the American Academy of Pediatrics Advocacy Committee, California Chapter 1 (AAP-CA1) and in her time helped launch the inaugural Advocating for Children Together conference for Northern California that became a yearly occurrence. She co-founded the Climate and Health Committee for AAP-CA1, and is a member of the Executive Committee for the AAP's national Council on Environmental Health and Climate Change. In these roles, she has co-led successfully introducing board certification materials on climate change into the American Board of Pediatrics, and written policy statements and book chapers for the AAP on plant-forward diets and climate-smart schools. She is formerly the rotation director for the pediatric resident's Community Pediatrics and Child Advocacy Rotation. Her extensive work in local advocacy was recognized by Stanford Children’s Health Advocacy Award in 2023.
She is currently the Executive Director for the Medical Society Consortium on Climate and Health and maintains a clinical practice as a pediatric hospitalist caring for newborns, premature infants, and children requiring hospitalization. She serves on several boards and commissions, including Our Children's Trust, the legal organization that represented youth in Held v. Montana, Undaunted K12 whose mission is to facilitate climate-smart schools throughout the country, and the National Commission on Climate and Workforce Health which empowers businesses to protect their workers from mounting threats to their health from climate change. She is frequently asked to advise and review on topics including sustainable healthcare, early childhood development and climate, vegetarian and plant-forward diets, and communicating climate change as a health threat.
Communications remains a central part of her work, and she serves as a Science Mom to talk to other parents and caretakers about the health harms of climate change. Her work has also appeared in the New England Journal of Medicine, the New York Times, the LA Times, Bloomberg News, and multiple state and local outlets. She is interviewed regularly for her expertise on climate, health, and equity for major national media outlets like the Washington Post, US News and World Report, and CNN, among others. -
Meeta Raman Patel
Adjunct Clinical Assistant Professor, Pediatrics - Gastroenterology
BioDr. Patel has been working with children with autism and other disabilities for 30 years. She is a Board Certified Behavior Analyst. Dr. Patel received a BS degree from the University of California at Davis in 1996 in Psychology with an emphasis in Biology. She continued her graduate training in Psychology at the University of Nevada, Reno. Dr. Patel received her PhD in Psychology with an emphasis in Behavior Analysis under the supervision of Dr. James Carr, Dr. Patrick Ghezzi, and Dr. Sidney Bijou in 2000.
She completed a post-doctoral fellowship at the Kennedy Krieger Institute and Johns Hopkins University School of Medicine in 2001 under the supervision of Dr. Cathleen Piazza and Dr. Wayne Fisher. Dr. Patel joined the faculty at the Marcus and Kennedy Krieger Institutes in 2001 and Emory University School of Medicine in 2002. Dr. Patel was a case manager in the Pediatric Feeding Disorders and Early Intervention Programs at the Marcus and Kennedy Krieger Institutes from 2001-2003. In 2003, she started Clinic 4 Kidz, which is a Home-Based Interdisciplinary Pediatric Feeding Disorders Program. Currently, she serves as the Executive Director of Clinic 4 Kidz. Dr. Patel is also an Adjunct Clinical Assistant Professor in the Department of Pediatrics, Division of Gastroenterology at Stanford University School of Medicine.
Her research and clinical interests focus on treating feeding problems in children who have underlying medical issues or children diagnosed with avoidant/restrictive food intake disorder. In addition, she has expertise in working with children with autism and other developmental disabilities.
She is currently an associate editor for Frontiers in Child and Adolescent Psychiatry. Dr. Patel is also on the editorial boards of Behavior Analysis in Practice and Journal of Developmental and Physical Disabilities. She is serving as a guest editor for the research topic “Unpacking the Correlation between Feeding Difficulties and Feeding Disorders in Children and Adolescents” for Frontiers in Child and Adolescent Psychiatry. Dr. Patel also serves as a guest reviewer for several behavioral and pediatric journals. She has published research studies in peer-reviewed journals and has authored invited book chapters. Dr. Patel has also been invited to present at numerous conferences and at various hospitals all over the world.
Dr. Patel also serves on the Board of Trustees for the Schools of the Sacred Heart, San Francisco and on she is on the Clinical Advisory Board for the MEAL PlanR project funded by the Georgia Research Alliance. -
Meghna D Patel
Clinical Associate Professor, Pediatrics - Cardiology
Current Research and Scholarly InterestsMy current academic focus is in chronic heart failure and ventricular assist device.
-
Michele Lanpher Patel
Instructor, Medicine - Stanford Prevention Research Center
BioMichele L. Patel, PhD is an Instructor in the Stanford Prevention Research Center at the Stanford University School of Medicine. Trained as a clinical health psychologist, Dr. Patel conducts research to optimize scalable digital health interventions for adults with obesity. She leads clinical trials that test innovative strategies to address the critical challenge of suboptimal engagement in digital interventions.
Dr. Patel's research is supported by an NIH career development award (K23; 2022-2027). Her recent Spark trial investigated the most potent combination of self-monitoring strategies in a behavioral weight loss intervention among 176 adults with overweight or obesity. Results are expected to be published in 2026.
She is also testing other strategies to promote engagement, weight loss, and health. This includes the impact of easier vs. harder goals, and the effect of high-frequency, low-friction behavioral strategies. Her work leverages the Multiphase Optimization Strategy (MOST) to systematically identify intervention strategies that maximize effectiveness while minimizing patient burden.
Dr. Patel received her PhD in clinical psychology from Duke University. She completed her clinical internship at the VA Palo Alto with a specialization in behavioral medicine, followed by a postdoctoral fellowship (T32) at the Stanford Prevention Research Center. She currently serves as the Chair of the Optimization of Behavioral and Biobehavioral Interventions special interest group in the Society of Behavioral Medicine.
Primary Research Interests:
-- Optimizing digital interventions for obesity treatment and prevention
-- Leveraging behavioral science to create lower-burden self-monitoring strategies to improve engagement and outcomes
-- Identifying psychosocial factors (including health literacy and self-efficacy) that influence treatment success
Methodological Expertise:
-- Randomized clinical trials, including factorial designs and embedded trials
-- Systematic reviews
-- Signal detection analysis -
Neha Patel, MD
Clinical Assistant Professor, Medicine - Oncology
BioDr. Neha Patel is a triple board-certified, fellowship-trained medical oncologist with Stanford Health Care. She is also a clinical assistant professor in the Department of Medicine, Division of Oncology at Stanford University School of Medicine.
Dr. Patel provides expert, personalized care for patients with both common and rare cancers and specializes in treating patients with genitourinary cancer. She is deeply committed to delivering comprehensive, patient-centered oncology services, with an emphasis on helping individuals and their families understand their diagnosis and navigate treatment options with confidence and clarity.
Her research focuses on designing and implementing system-level interventions to advance equitable, high-value cancer care. Dr. Patel is particularly passionate about integrating oncology and palliative (symptom-relieving) care—creating collaborative models that improve patient outcomes, elevate the quality of life, and enhance the overall care experience.
Known for her compassionate and relational approach, Dr. Patel builds strong, trusting partnerships with the patients and families she serves. She prioritizes care that aligns with each individual’s values, preferences, and goals, with the aim of achieving the best possible quality of life and longevity. -
Ruby Vishnu Patel
Clinical Assistant Professor, Pediatrics - Nephrology
BioI am a Clinical Assistant Professor in the Division of Pediatric Nephrology at Stanford. I have completed my pediatric nephrology fellowship from Stanford Children's Hospital and Residency as well as Chief Resident Year from The Kaiser Permanente Northern California Pediatrics Residency Program.
